Schedule 13D ownership disclosure
Asterias Biotherapeutics, Inc.
Security class unavailable · CUSIP: 04624N107
Event date: 2020-01-02
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 10.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-20-000239
- Form type
- SC 13D
- Filer
- Lineage Cell Therapeutics, Inc.
- CIK
- CIK 876343
- Filed
- Jan 06, 2020
- Reporting period
- Jan 02, 2020
- Description
- Schedule 13D beneficial ownership